<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03003988</url>
  </required_header>
  <id_info>
    <org_study_id>IRB2014-0503FX</org_study_id>
    <nct_id>NCT03003988</nct_id>
  </id_info>
  <brief_title>Physiological Effects of Creatine Supplementation in Active Males</brief_title>
  <acronym>NB4</acronym>
  <official_title>Effects of 28 Days of Different Forms of Creatine Supplementation on Muscle Creatine, Body Composition and Exercise Performance in Recreationally Active Males</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas A&amp;M University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nutrabolt</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Texas A&amp;M University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was designed to examine how different forms of creatine impact active males.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study examined the effects of different formulations of creatine nitrate on muscle
      creatine content, body composition, anaerobic exercise capacity, bench press performance and
      clinical chemistry panels in recreationally active males.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effects of 28 Days of Different Forms of Creatine Supplementation on Body Water</measure>
    <time_frame>28 Days</time_frame>
    <description>Assessing Body Water through Bioelectrical Impedance Analysis (BIA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effects of 28 Days of Different Forms of Creatine Supplementation on Body Composition</measure>
    <time_frame>28 Days</time_frame>
    <description>Assessing Body Compositing through Dual-Energy X-Ray Absorptiometry (DXA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effects of 28 Days of Different Forms of Creatine Supplementation on intramuscular creatine</measure>
    <time_frame>28 Days</time_frame>
    <description>Assessing intramuscular creatine using standard spectrophotometric methods using a microplate spectrophotometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effects of 28 Days of Different Forms of Creatine Supplementation on intramuscular phosphocreatine</measure>
    <time_frame>28 Days</time_frame>
    <description>Assessing intramuscular phosphocreatine using standard spectrophotometric methods using a microplate spectrophotometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effects of 28 Days of Different Forms of Creatine Supplementation on intramuscular ATP</measure>
    <time_frame>28 Days</time_frame>
    <description>Assessing intramuscular Adenosine Triphosphate (ATP) using standard spectrophotometric methods using a microplate spectrophotometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effects of 28 Days of Different Forms of Creatine Supplementation on muscular strength</measure>
    <time_frame>28 Days</time_frame>
    <description>Assessing muscular strength through 1 Repetition Maximum (RM) testing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effects of 28 Days of Different Forms of Creatine Supplementation on muscular endurance</measure>
    <time_frame>28 Days</time_frame>
    <description>Assessing muscular endurance through repetition to failure testing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effects of 28 Days of Different Forms of Creatine Supplementation on anaerobic capacity</measure>
    <time_frame>28 Days</time_frame>
    <description>Assessing anaerobic capacity through 6 x 6 second sprints followed by a 30 second sprint on a Wingate bicycle ergometer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effects of 28 Days of Different Forms of Creatine Supplementation on training volume (weight lifted x number of repetitions x number of sets)</measure>
    <time_frame>28 Days</time_frame>
    <description>Assessing training volume using a calculator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects of 28 Days of Different Forms of Creatine Supplementation on self-reported side effects</measure>
    <time_frame>28 Days</time_frame>
    <description>Assessing self-reported side effects using a side effects questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects of 28 Days of Different Forms of Creatine Supplementation on blood</measure>
    <time_frame>28 Days</time_frame>
    <description>Measure standard clinical chemistry panels in the blood to evaluate safety</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Dietary Supplementation</condition>
  <arm_group>
    <arm_group_label>Creatine monohydrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Creatine monohydrate (6.0 g.) + dextrose (0.5 g.)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Creatine nitrate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Creatine nitrate (5.0 g. creatine monohydrate + 1.5 g. creatine nitrate that provides 1.0 g. of creatine and 0.5 g. nitrate in 2:1 ratio).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>6.5 g. dextrose</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Creatine monohydrate</intervention_name>
    <description>Creatine monohydrate (6.0 g) + dextrose (0.5 g)</description>
    <arm_group_label>Creatine monohydrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Creatine nitrate</intervention_name>
    <description>Creatine nitrate (5.0 g creatine monohydrate + 1.5 g. creatine nitrate that provides 1.0 g. of creatine and 0.5 g. nitrate in 2:1 ratio)</description>
    <arm_group_label>Creatine nitrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo (6.5 g dextrose)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  participants are apparently healthy and recreationally active males between the ages
             of 18 and 40;

          -  participants will need to have at least six months immediate prior history of
             resistance training on the bench press and leg press or squat;

        Exclusion Criteria:

          -  participants have a history of treatment for metabolic disease (i.e., diabetes),
             hypertension, hypotension, thyroid disease, arrhythmias and/or cardiovascular disease;

          -  participants are currently using prescription medications;

          -  participants have a history of smoking;

          -  participants drink excessively (i.e., 12 drinks per week or more);

          -  participants have a recent history of creatine supplementation within six weeks of the
             start of supplementation;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard B Kreider, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas A&amp;M University</affiliation>
  </overall_official>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2016</study_first_submitted>
  <study_first_submitted_qc>December 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2016</study_first_posted>
  <last_update_submitted>January 2, 2017</last_update_submitted>
  <last_update_submitted_qc>January 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

